Aziz Jafarov / Richard Laing

Slides:

Advertisements

Similar presentations

Examples of Community Needs Assessment:

Advertisements

Health in Prisons Project Establishing a Monitoring Mechanism on Prison Health Indicators and Health Determinants Working Party on Information on Lifestyle.

1 Bishkek November 17, Goulsara Pulatova RegionalCoordinator UNISDR Secretariat Office in Central Asia 2nd Regional Consultative.

1. Health Policy Research Group Department of Pharmacology & Therapeutics, College of Medicine, University of Nigeria Enugu Campus 2. Department of Clinical.

Antenatal Care = Prenatal Care Is the complex of interventions that a pregnant woman receives from organized health care services. 1.

AND GENERIC DRUGS BRAND-NAME AND GENERIC DRUGS WHAT TO CHOOSE? Natalia VEZIKOVA, MD, PhD, Natalia VEZIKOVA, MD, PhD, MSc The Head of the Hospital Therapy.

Slide 1 Summary of responses on multidimensional poverty measurement (Eastern Europe, Caucasus and Central Asia) UNECE 4 May 2015.

The Global Plan to Stop TB, (1)

Marketing Research Aaker, Kumar, Day and Leone Tenth Edition Instructor’s Presentation Slides.

Trade Facilitation: A Regional Perspective Regional Policy Forum on Trade Facilitation in Times of Crisis May 2009, Beijing, China.

Advocating for Harm Reduction: A Public Health Response to Drug Use and HIV in Eastern Europe and Central Asia Sue Simon International Harm Reduction Development.

PEM -PAL 13th INTERNATIONAL CONFERENCE ON INTERNAL AUDIT , Hotel Granit, Ohrid.

 Dushanbe,Tajikistan Ganieva Gulfiza, ES-111

2003 grant Foundation for European Forest Research Forestry activities of international organizations in relation to the needs and expectations of Central.

Daniel Gay Istanbul, 18 November 2008 Regional Report on Trade and Human Development in Central Asia.

Food security and climate change in Central Asia Osmanova Inna, June 24,2015, Ormea.

Medicine Prices, Availability, Affordability and Price Components in Kazakhstan, Kyrgystan, Tajikistan & Uzbekistan Margaret Ewen Health Action International.

Overview on production and sharing of 8 selected indicators by Central Asian countries MONECA Regional Coordination Meeting, 10 June 2014, Almaty, Kazakhstan.

KYRGYZSTAN AND KYRGYZ NATIONAL UNIVERSITY Chinara Adamkulova.

Abstract ID: 395 Author Name: Araya Sripairoj Presenter Name: Araya Sripairoj Authors: Sripairoj A, Liamputtong P, Harvey K.

UN Development Account Project “Strengthening the Statistical Capacity of Central Asian countries” Concluding Session “How Can the International Community.

Population of the World. Purpose How does the population of the different continents compare?

COMPARATIVE ANALYSIS OF SELECTED ESSENTIAL DRUG LISTS AZIZ JAFAROV/RICHARD LAING.

Regional Seminar on Promotion and Utilization of Census Results and on the Revision on the United Nations Principles and Recommendations for Population.

Interstate Statistical Committee of the Commonwealth of Independent Sate ( CIS Stat Commettee ) Population Census Round 2010 in CIS countries: key results.

CONTRACEPTIVE SECURITY Issues for Central Asian Republics Issues for Central Asian Republics USAID SOTA Course October, 2002 Washington DC Mary Skarie,

TEMPUS. GENERAL OBJECTIVES Contribute to socio-economic reform and development Reinforce civil society Promote intercultural understanding.

MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,

DOES DRUG USE EVALUATION (DUE) REQUIRED BY NATIONAL POLICY IMPROVE USE OF MEDICINES?

MAP OF CENTRAL ASIA Illustrations of country and administry countries.

Does Drug Use Evaluation Required by National Policy Improve Use of Medicines? Akaleephan C*, Muenpa R**, Sittitanyakit B***, Treesak C #, Cheawchanwattana.

Update dose-effect relations for annoyance for aircraft noise Martin van den Berg Steering group noise Tampere.

Copyright 2010, The World Bank Group. All Rights Reserved. Core and Supplementary Agricultural Topics Section A 1.

R-UNDG ECA Working Group on Social Protection UNDG Europe and Central Asia Regional Directors Meeting Geneva, 12 May Progress to date.

MULTI-CULTURAL EDUCATION IN THE MURMANSK REGION: PROBLEMS AND PERSPECTIVES Alexandra Burtseva, PhD in Pedagogy, Murmansk State Humanities University.

Chapter 12 Lesson 12.2b Comparing Two Populations or Treatments 12.2: Test for Homogeneity and Independence in a Two-way Table.

R-UNDG ECA Working Group on Social Protection UNDG Europe and Central Asia Working Group on Social Protection Focal Points Meeting 30 May Introduction.

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies (Updated Review) Presenter: Angela Acosta Funding Sources.

St. Edward’s University

on Youth and Gender Statistics

Statistical Business Register in Eastern Europe, Caucasus and Central Asia Workshop on Business Registers and their Role in Business Statistics in the.

Social Responsibilities of Companies in Kazakhstan

Quality assurance in population and housing census SUDAN’s EXPERIANCE in QUALITY assurance of Censuses By salah El din. A . Magid OUR EXPERIANCE IN 5.

George Bouma Regional Cluster Leader, Sustainable Development,

Migration from Central Asian countries, гг. (mille).

Institute of Law – Birzeit University

Aaker, Kumar, Day Ninth Edition Instructor’s Presentation Slides

Pharmacy and Therapeutics Committees in Thai Hospitals under Health Reform Sripairoj A, Liamputtong P, Harvey K La Trobe University, Australia.

Newly diagnosed HIV infections per million population

Evaluating Sepsis Guidelines and Patient Outcomes

Presented by (May 4, 2015): Sanat K. Bhowmik Director

IMPACT - CANEM II PARTNERSHIP

Central Asian Health Profiles 2012

Would You Approve It? The Xenadrine brand name is often linked to health risks associated with taking diet pills, particularly because it contains the.

MACROECONOMICS AND HEALTH

Cumulative reported HIV infections per million population

E-learning as a key component of the Medical Education

Annual newly diagnosed HIV infections per million population

Real interest rate parity hypothesis in post-Soviet countries: Evidence from unit root tests 張芯瑜.

Regional Seminar on Developing a Program for the Implementation of the 2008 SNA and Supporting Statistics Gülfer DİKBAYIR September 2013 Ankara.

ABSTRACT Qualitative and Quantitative Assessment of the Essential Medicines List of Delhi State: A Time Series Analysis. Gupta U, Sangeeta S, Baishya.

CORPORATE SOCIAL RESPONSIBILITY

Health reform: The human resource challenges for Central Asian Commonwealth of Independent States (CIS) countries Barbara Parfitt, CBE, PhD, RN Collegian

Toktobaeva B, Karymbaeva S Drug Information Centre Kyrgyzstan

Bulgaria – Capital Budgeting And Fiscal Institutions

GROUP 2 Belarus, Kyrgyzstan, Kazakhstan, Moldova, Russia, Uzbekistan,

CAR and Kazakhstan Aikan Akanov, MD, PhD, DSci (Medicine)

Demographics of Russia and the Republics

Central Asia after the Soviet Union

CAREC REGIONAL INTEGRATION INDEX

Presentation transcript:

Aziz Jafarov / Richard Laing Comparative analysis of essential drug lists in four Central Asian Republics. Aziz Jafarov / Richard Laing

Population and health financing in Kazakhstan, Kyrgyzstan, Tajikistan and Uzbekistan

Method Сompares the existing Essential Drug Lists of Kazakhstan, Kyrgyzstan, Uzbekistan, and Tajikistan with the WHO Model EDL List. For the purpose of this analysis, we have combined core and complementary drugs into a single master list. For this paper a comparative table has been developed and the WHO Model EDL was taken as the standard.

Method 1) on the WHO Model EDL 2) From the same therapeutic group Drugs on national EDLs were classified as being: 1) on the WHO Model EDL 2) From the same therapeutic group 3) Not included on the WHO Model List. Based on the spreadsheet, summary tables were developed for all the EDLs and the WHO Model List and some of the therapeutic groups in order to compare with the national and the WHO list.

Comparative table of EDLs of CAR and WHO Model List SUMMARY

Forms and doses

Cardiovascular drugs

Gastrointestinal drugs

Drugs affecting the blood, blood products and plasma

Recommendation Design and conduct in-depth studies to evaluate the selection process in each country of the region and introduce and update the selection process according to the latest developments Organize meetings at regional level on the EDL concept Reduce the number of forms and doses in the EDLs Exclude the column of brand names as alternatives for generic names

Conclusion The number of EDs among the countries, the drugs selected for the national lists, and the excessive number of forms and doses in the lists controversial. Inclusion of the brand names in a separate column in some of the countries’ EDLs creates room for misinterpretation and for bad procurement practices. At least some of the selected drugs and the selection process itself require revision. Local institutions contributed to the process of the development and revision of the lists, and there is knowledge and interest in the ED concept.